KhabarAdda
Aggregated from Times of India, NDTV, Hindustan Times, India Today and more · Every source linked and credited · Updated every 15 minutes
PM Modi calls Sharad Pawar, advises rest as NCP (SP) chief discharged from hospitalIran war, inflation or Trump fatigue: What drove Democrats’ midterm surge?BJP had no role to play, says Ram Madhav as friction in NC intensifiesDerek O’Brien hits back at Amit Shah over SIR debate, recalls 2025 Rajya Sabha proceedingsBengal man arrested from temple with wife’s severed head; neighbours allege marital discordPramila Jayapal To Ro Khanna: How Indian-Origin Faces Are Performing In US ElectionsDemocrats Win Senate, End Republican Dominance In House. Trump Posts “Veto”Sam Altman doesn’t want AI deciding what humans doExclusive | ‘End Iran War, Lower Tariffs’: Suhas Subramanyam’s Goals After Big US Midterms WinMeet Zorba, India’s first anti-poaching dog who helped catch 60 rhino poachers
Business

Bharat Biotech is ‘back in action’ after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s next

viaeconomictimes.indiatimes.com21 Sept
Bharat Biotech is ‘back in action’ after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s next
Bharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines into cell and gene therapy and monoclona

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.

Read the full story on economictimes.indiatimes.com ↗